FLEXION THERAPEUTICS INC - COM (FLXN)

CUSIP: 33938J106

Q4 2016 13F Holders as of 31 Dec 2016

Type / Class
Equity / COM
Total 13F shares
22,841,362
Share change
+3,896,988
Total reported value
$434,273,369
Put/Call ratio
35%
Price per share
$19.02
Number of holders
93
Value change
+$73,974,268
Number of buys
65
Number of sells
25

Quarterly Holders Quick Answers

What is CUSIP 33938J106?
CUSIP 33938J106 identifies FLXN - FLEXION THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FLEXION THERAPEUTICS INC - COM (FLXN) as of Q4 2016

As of 31 Dec 2016, FLEXION THERAPEUTICS INC - COM (FLXN) was held by 93 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 22,841,362 shares. The largest 10 holders included GILDER GAGNON HOWE & CO LLC, Capital World Investors, Bank of New York Mellon Corp, Novo A/S, KINGDON CAPITAL MANAGEMENT, L.L.C., BlackRock Fund Advisors, VANGUARD GROUP INC, TPG Group Holdings (SBS) Advisors, Inc., WASATCH ADVISORS INC, and PEREGRINE CAPITAL MANAGEMENT LLC. This page lists 93 institutional shareholders reporting positions in this security for the Q4 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.